Stock Events

Stock Events

Abbott Laboratories 

C$19.17
4661
-C$0.60-3.03%Friday 20:36

Statistics

Day High
19.44
Day Low
19.17
52W High
24.81
52W Low
19.17
Volume
2,400
Avg. Volume
5,084
Mkt Cap
33.17B
P/E Ratio
13.23
Dividend Yield
18.57%
Dividend
3.56

Upcoming

Dividends

18.57%Dividend Yield
Nov 2026
C$0.89
Aug 2026
C$0.87
May 2026
C$0.86
Feb 2026
C$0.86
Nov 2025
C$0.83
10Y Growth
9.29%
5Y Growth
7.72%
3Y Growth
7.43%
1Y Growth
6.9%

Earnings

Jan 27Expected
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Q3 2026
Next
1.14
1.31
1.47
1.64
Expected EPS
1.637788
Actual EPS
N/A

Financials

14.69%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
61.62BRevenue
9.05BNet Income

Analyst Ratings

$133.78Average Price Target
The highest estimate is ⁦141.87⁩.
From 13 ratings within the last 6 months. This is not an investment recommendation.
Buy
92%
Hold
8%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ABT.NEO. It's not an investment recommendation.
Apple
1128
AAPL
Microsoft
1105
MSFT
Coca-Cola
955
KO
Johnson & Johnson
953
JNJ

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson competes with Abbott in multiple segments including medical devices, diagnostics, and pharmaceuticals, making it a direct competitor across several of Abbott's business lines.
Medtronic
MDT
Mkt Cap123.49B
Medtronic competes with Abbott in the medical devices sector, particularly in cardiovascular and diabetes care products.
Thermo Fisher Scientific
TMO
Mkt Cap257.71B
Thermo Fisher Scientific competes with Abbott in the diagnostics and life sciences sector, offering a range of analytical instruments, reagents, and consumables.
Danaher
DHR
Mkt Cap163.25B
Danaher Corporation competes with Abbott in the diagnostics and life sciences industry, particularly through its subsidiary Cepheid, which offers molecular diagnostics solutions.
Boston Scientific
BSX
Mkt Cap60.84B
Boston Scientific competes with Abbott in the medical devices sector, especially in cardiovascular products.
Baxter International
BAX
Mkt Cap11.9B
Baxter International competes with Abbott in the medical devices and nutrition sectors, offering products for critical care, nutrition, renal care, and more.
Stryker
SYK
Mkt Cap111.95B
Stryker competes with Abbott in the medical devices sector, particularly in orthopedics, which indirectly competes with Abbott's offerings in other medical device categories.
Becton Dickinson
BDX
Mkt Cap53.9B
Becton, Dickinson and Company competes with Abbott in the medical technology sector, offering devices, laboratory equipment, and diagnostic products.
Resmed
RMD
Mkt Cap32.34B
ResMed competes with Abbott in the health sector by providing medical devices for sleep disorders and respiratory conditions, which complements Abbott's broader medical device portfolio.

About

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
Show More
CEO
Robert Ford
Employees
115000
Country
United States
ISIN
CA0028221046

Listings

XETRA
DE
ABL.XETRA
MI
IT
1ABT.MI
F
DE
ABL0.F
ST
SE
ABTO.ST

0 Comments

Share your thoughts

FAQs

What is Abbott Laboratories stock price today?▼
The current price of ABT.NEO is C$19.17 CAD — it has decreased by -3.03% in the past 24 hours. Watch Abbott Laboratories stock price performance more closely on the chart.
What is Abbott Laboratories stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on NEO Exchange exchange Abbott Laboratories stocks are traded under the ticker ABT.NEO.
Is Abbott Laboratories stock price growing?▼
ABT.NEO stock has risen by +3.51% compared to the previous week, the month change is a +11.78% rise, over the last year Abbott Laboratories has showed a -14.42% decrease.
What is Abbott Laboratories market cap?▼
Today Abbott Laboratories has the market capitalization of 33.17B
When is the next Abbott Laboratories earnings date?▼
Abbott Laboratories is going to release the next earnings report on January 27, 2027.
What were Abbott Laboratories earnings last quarter?▼
ABT.NEO earnings for the last quarter are 1.99 CAD per share, whereas the estimation was 1.99 CAD resulting in a +0.03% surprise. The estimated earnings for the next quarter are N/A CAD per share.
What is Abbott Laboratories revenue for the last year?▼
Abbott Laboratories revenue for the last year amounts to 61.62B CAD.
What is Abbott Laboratories net income for the last year?▼
ABT.NEO net income for the last year is 9.05B CAD.
Does Abbott Laboratories pay dividends?▼
Yes, ABT.NEO dividends are paid quarterly. The last dividend per share was 0.11 . As of today, Dividend Yield (FWD)% is 18.57%.
How many employees does Abbott Laboratories have?▼
As of November 7, 2026, the company has 115,000 employees.
In which sector is Abbott Laboratories located?▼
Abbott Laboratories operates in the Health & Wellness sector.
When did Abbott Laboratories complete a stock split?▼
Abbott Laboratories has not had any recent stock splits.
Where is Abbott Laboratories headquartered?▼
Abbott Laboratories is headquartered in ABBOTT PARK, United States.